Rodo Tablet

Adult dose

For adults and children over 15 years old, 2 tablets orally 2-3 times a day.

Child dose

For ages 10-14, 1 tablet orally 3 times a day. For ages 6-9, 1 tablet orally 2 times a day.

This medication may prolong the QT interval, affecting the heart's electrical activity and increasing the risk of cardiac arrhythmias or rhythm disturbances. Special caution is advised for patients with congenital QT prolongation, those taking certain medications, patients with electrolyte imbalances, those with heart disease, the elderly, newborns, and women. Serious skin reactions may occur while taking this medication; if symptoms such as skin rash or mucosal damage appear, administration should be ceased immediately. Patients with certain genetic disorders may be at risk of liver damage, so liver function tests must be performed both before and during treatment, and if any liver dysfunction is detected, the medication should be discontinued. Patients with allergic reactions or hypersensitivity to certain drugs, children under 6 years old, and those with specific hereditary metabolic disorders should not take this medication. Various side effects can occur, including skin rash, gastrointestinal issues, blood disorders, neurological problems, psychiatric symptoms, vision changes, liver dysfunction, cardiac arrhythmias, and hearing impairments have been reported. In particular, if changes in mental state, seizures, or dizziness occur, it is crucial to consult a physician immediately and avoid driving or operating machinery. This medication should only be used for the necessary duration to prevent the development of resistant bacteria, and alcohol should be avoided as it may increase the risk of side effects. Additionally, regular blood tests are required for those with a history of blood disorders, and patients should be aware that urine color may change during treatment. This medication can interact with various other drugs, so consultation with a physician is mandatory when using it alongside warfarin, lithium, cyclosporine, anticoagulants, etc., and blood tests should be used to monitor the condition. It is recommended to avoid taking it during the first three months of pregnancy, and breastfeeding should be discontinued while taking this medication. In case of overdose, symptom-specific treatment and cardiac monitoring are necessary. Finally, store this medication out of the reach of children, and do not transfer the medication to another container for safety.

Serious side effects

Urticaria, severe swelling (edema), anaphylactic shock, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, angioedema, vasculitis, jaundice and liver abnormalities, QT prolongation, ventricular arrhythmias, ventricular tachycardia, Torsades de pointes, cardiac arrest, hearing impairment/hearing loss, acute liver failure, acute hemolysis, severe skin adverse reactions, severe

Mild side effects

Rash, itching, flushing, fixed drug eruption, linear IgA disease, vasculitis, upper abdominal pain, nausea, vomiting, diarrhea, oral mucositis, taste disturbance, decreased appetite, tongue discoloration/white coating, membranous colitis, acute hemolysis, leukopenia, neutropenia, agranulocytosis, thrombocytopenia, dizziness, lack of coordination, ataxia, sensory disturbances, multiplex neuritis of sensory and motor nerves, confusion, hallucinations, depressed mood, double vision, myopia,

This medication must be stored in a tightly sealed container to protect it from air and moisture. The appropriate storage temperature is in a cool place between 1 degree and 25 degrees.

Appearance

White round film-coated tablet engraved with 302AV on one side

Package unit

20 tablets (10 tablets/blister*2)